Advanced Biomed is trading 9.65% down in pre-market at $7.40, while the specific catalyst remains unclear.

  • It closed at $8.19 on August 20, 2026.
  • No reliable August 21 company-specific announcement, earnings release, or regulatory catalyst was identified; available coverage is older.
  • The broader market is higher in pre-market, and the decline may reflect continued volatility and profit-taking, but it does not clearly track index sentiment.